OREM, UT and SAN DIEGO, CA , a leading provider of online
business optimization software, and Visual Sciences, Inc. (formerly
known as WebSideStory, Inc.) (NASDAQ: VSCN), today announced that
in connection with Omniture's previously announced proposed
acquisition of Visual Sciences, early termination of the waiting
period under the Hart-Scott-Rodino Antitrust Improvements Act of
1976 (the HSR Act) has been granted by the U.S. Federal Trade
Commission.
"We are pleased to have completed this important step towards
closing our proposed acquisition of Visual Sciences," said Josh
James, CEO and co-founder of Omniture. "We look forward to bringing
the benefits of this acquisition to our customers, partners and
stockholders in the early part of 2008."
The acquisition, which is now expected to close in the first
quarter of 2008, is subject to approval of stockholders of both
companies and other customary closing conditions.
About Omniture
Omniture, Inc. is a leading provider of online business
optimization software, enabling customers to manage and enhance
online, offline and multi-channel business initiatives. Omniture's
software, which it hosts and delivers to its customers as an
on-demand subscription service, enables customers to capture, store
and analyze information generated by their Web sites and other
sources and to gain critical business insights into the performance
and efficiency of marketing and sales initiatives and other
business processes. In addition, Omniture offers a range of
professional services that complement its online services,
including implementation, best practices, consulting, customer
support and user training through Omniture University(TM).
Omniture's more than 2,700 customers include eBay, AOL, Wal-Mart,
Gannett, Microsoft, Neiman Marcus, Oracle, Countrywide Financial,
General Motors, Sony and HP. Website: www.omniture.com. Omniture is
a registered trademark of Omniture, Inc.
About Visual Sciences
Founded in 1996, Visual Sciences, Inc. (formerly known as
WebSideStory, Inc.) (NASDAQ: VSCN) is a leading provider of
real-time analytics applications. The company's analytics
applications, based on its patent pending on-demand service and
software platform, enable fast and detailed analytics on large
volumes of streaming and stored data. Approximately 1,590
enterprises worldwide rely on the answers delivered by these
applications to provide them with actionable intelligence to
optimize their business operations. The company provides real-time
analytics applications for web sites, contact centers, retail
points-of-sale, messaging systems and the intelligence community.
In addition, the company's line of analytics-driven offerings
leverages its analytics technology to automatically optimize Web
sites and related marketing applications. Visual Sciences flexible
technology platform, Visual Sciences Technology Platform 5(TM),
allows the company to rapidly introduce tailored solutions to meet
its clients' needs. Visual Sciences is headquartered in San Diego,
Calif., and has East Coast offices in Herndon, Virginia and a
European headquarters in Amsterdam, The Netherlands. For more
information, contact Visual Sciences. Voice: 858.546.0040. Fax:
858.546.0480. Address: 10182 Telesis Court, 6th Floor, San Diego,
CA 92121. Web site: www.visualsciences.com. Visual Sciences is a
registered trademark of Visual Sciences, Inc.
Note on Forward Looking Statements
Management believes that certain statements in this release may
constitute "forward-looking statements" within the meaning of
Section 21E of the Securities Exchange Act of 1934 and Section 27A
of the Securities Act of 1933, including, but not limited to,
statements regarding our ability to complete the acquisition, the
ability to satisfy conditions to closing, including obtaining
stockholder approvals and the benefits of the acquisition to
customers, partners and stockholders. These statements are based on
current expectations and assumptions regarding future events and
business performance and involve certain risks and uncertainties
that could cause actual results to differ materially, including,
but not limited to, risks associated with obtaining stockholder
approvals, risks associated with disruption to our business as a
result of the acquisition, the possibility that despite expiration
of the waiting period governmental entities may still challenge the
acquisition before or after its completion, risks that the expected
financial effect of the acquisition may not be realized, risks that
the expected customer benefits may not be realized and risks
associated with the operation of our business or our industry
generally, including risks associated with changes in the demand
for our services, the potential that Omniture or its customers may
not realize the benefits Omniture currently expects from its recent
acquisitions, risks inherent in the integration and combination of
complex products and technologies, our ability to continue to
attract new customers and sell additional services to our existing
customers, the continued adoption by customers of our SiteCatalyst
service and other product and service offerings, the significant
capital requirements of our business model that make it more
difficult to achieve positive cash flow and profitability if we
continue to grow rapidly, our ability to develop or acquire new
services, risks associated with our acquisition strategy and
disruptions in our business and operations as a result of
acquisitions, possible fluctuations in our operating results and
rate of growth, the continued growth of the market for on-demand,
online business optimization services, changes in the competitive
dynamics of our markets, the inaccurate assessment of changes in
our markets, errors, interruptions or delays in our services or
other performance problems with our services, our ability to hire,
retain and motivate our employees and manage our growth, our
ability to effectively expand our sales and marketing capabilities,
our ability to develop and maintain strategic relationships with
third parties with respect to either technology integration or
channel development, our ability to expand the sales of our
services to customers located outside the United States, our
ability to implement and maintain proper and effective internal
controls, the adoption of laws or regulations, or interpretations
of existing law, that could limit our ability to collect and use
Internet user information, and the blocking or erasing of
"cookies"; and such other risks as identified in Omniture's
quarterly report on Form 10-Q for the period ended September 30,
2007, and from time to time in other reports filed by Omniture with
the U.S. Securities Exchange Commission. These reports are
available on our Web site at www.omtr.com. Omniture undertakes no
duty to update any forward-looking statement to conform the
statement to actual results or changes in the Company's
expectations.
Additional Information and Where You Can Find It
Omniture has filed with the SEC a preliminary Registration
Statement on Form S-4, which includes a preliminary joint proxy
statement/prospectus of Omniture and Visual Sciences and other
relevant materials in connection with the proposed transaction. The
definitive joint proxy statement/prospectus will be mailed to the
stockholders of Omniture and Visual Sciences. Investors and
security holders of Omniture and Visual Sciences are urged to read
the joint proxy statement/prospectus and the other relevant
materials when they become available because they will contain
important information about Omniture, Visual Sciences and the
proposed transaction. The joint proxy statement/prospectus and
other relevant materials (when they become available), and any
other documents filed by Omniture or Visual Sciences with the SEC,
may be obtained free of charge at the SEC's web site at
www.sec.gov. In addition, investors and security holders may obtain
free copies of the documents filed with the SEC by Omniture by
contacting Omniture's Investor Relations at ir@omniture.com or via
telephone at (801) 722-7037. Investors and security holders may
obtain free copies of the documents filed with the SEC by Visual
Sciences at vscn@marketstreetpartners.com or via telephone at (858)
546-0040. Investors and security holders are urged to read the
joint proxy statement/prospectus and the other relevant materials
when they become available before making any voting or investment
decision with respect to the proposed transaction.
Omniture and its respective directors and executive officers may
be deemed to be participants in the solicitation of proxies from
the stockholders of Omniture and Visual Sciences in favor of the
proposed transaction. Information about the directors and executive
officers of Omniture and their respective interests in the proposed
transaction is available in the joint proxy
statement/prospectus.
Visual Sciences and its respective directors and executive
officers may be deemed to be participants in the solicitation of
proxies from the stockholders of Visual Sciences and Omniture in
favor of the proposed transaction. Information about the directors
and executive officers of Visual Sciences and their respective
interests in the proposed transaction is available in the joint
proxy statement/prospectus.
Omniture Press Contact: Kristi Knight 801-722-7000 Email
Contact
Visual Sciences (MM) (NASDAQ:VSCN)
Historical Stock Chart
From Jan 2025 to Feb 2025
Visual Sciences (MM) (NASDAQ:VSCN)
Historical Stock Chart
From Feb 2024 to Feb 2025
